89 results
8-K
EX-99.2
ME
23andMe Holding Co - Ordinary Shares
8 Jan 24
Regulation FD Disclosure
7:45am
in the majority of samples tested ‘610 Differentiation: Inhibition of CD200R1 Has the Potential to Address Resistance to Anti–PD1 Therapies
29Copyright © 2024
S-8
ME
23andMe Holding Co - Ordinary Shares
15 Sep 23
Registration of securities for employees
4:06pm
, with respect to a person who is a director or officer at the time of such determination, (1) by a majority vote of the directors who were not parties … to such action, suit or proceeding, even though less than a quorum, or (2) by a committee of such directors designated by majority vote of such directors
S-8
EX-99.1
ME
23andMe Holding Co - Ordinary Shares
15 Sep 23
Registration of securities for employees
4:06pm
, will not, immediately after the merger or consolidation, constitute a majority of the board of directors of the surviving Person or (B) a sale or other … or less such that a majority of the Board members ceases, by reason of one or more contested elections, or threatened election contests, for Board
8-K
EX-99.1
uuhborapyw
1 Sep 23
23andMe Granted New FDA Clearance to Report Additional BRCA Variants
12:00am
8-K
bdcrs2hoibp
8 Aug 23
23andMe Reports FY2024 First Quarter Financial Results
4:10pm
DEFR14A
wfse9mf2
4 Aug 23
Revised proxy
4:05pm
DEFR14A
pbx3o1ryqp 3q
26 Jul 23
Revised proxy
9:14pm
8-K
5u6q3r8tbv8sw7
9 Jun 23
Cost Associated with Exit or Disposal Activities
4:05pm
8-K
EX-99.1
g2jv8cuk7
17 Apr 23
Regulation FD Disclosure
4:10pm
8-K
EX-99.1
wdxyvuuw
14 Apr 23
23andMe Announces Phase 1 Results from the First-in-Human Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1
4:08pm
8-K
EX-3.1
fcorpz8
9 Dec 22
Departure of Directors or Certain Officers
8:05am
8-K
EX-10.1
pwzz7z 12h
9 Dec 22
Departure of Directors or Certain Officers
8:05am
8-K
EX-99.1
0n1ux19orwcr0
9 Nov 22
Investor Presentation November 2022
7:30am
POS AM
qybe8bl
3 Nov 22
Prospectus update (post-effective amendment)
4:14pm
424B3
mcqou1e9z24
31 Aug 22
Prospectus supplement
8:53pm